Livingston Group Asset Management »

Adma Biologics shares owned by Livingston Group Asset Management

Quarter-by-quarter ownership of Adma Biologics (ADMA) shares owned by Livingston Group Asset Management from 13F filings

Historical chart of Livingston Group Asset Management investment in Adma Biologics

Tip: Access up to 7 years of quarterly data

All positions including Adma Biologics held by Livingston Group Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adma Biologics by Livingston Group Asset Management

Quarter filed Position value Share count Share price at filing
2022-03-31 $21k 12k 1.83

More positions owned by Livingston Group Asset Management

Apple (AAPL)
Microsoft Corporation (MSFT)
Proshares Tr Short Qqq New
CF Industries Holdings (CF)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Direxion Shs Etf Tr Dly Enrgy Bull2x (ERX)
Devon Energy Corporation (DVN)
Nutrien (NTR)
Broadcom (AVGO)
Dimensional Etf Trust Us Core Equity 2 (DFAC)
Cheniere Energy Com New (LNG)
Barrick Gold Corp (GOLD)
Vanguard Bd Index Fds Short Trm Bond (BSV)
Proshares Tr Pshs Short Dow30 (DOG)
Spdr Ser Tr Prtflo S&p500 Gw (SPYG)

View all positions for Livingston Group Asset Management

Top funds holding Adma Biologics

BlackRock
Vanguard Group
State Street Corporation
Invesco
Nuveen Asset Management
Geode Capital Management
D. E. Shaw & Co
Two Sigma Advisers
AWM Investment Company
American Century Companies
Deutsche Bank Aktiengesellschaft
Dimensional Fund Advisors
Renaissance Technologies
Perpetual
Two Sigma Investments

View all funds holding Adma Biologics